AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44

Authors: Gastmeier, P Beck, KD Lode, H
Citation: P. Gastmeier et al., Heat and moisture exchanging filters and pneumonia: many unresolved questions, DEUT MED WO, 126(30), 2001, pp. 835-839

Authors: Ruf, BR Lode, H
Citation: Br. Ruf et H. Lode, Current state of the study of infectious diseases in Germany, DEUT MED WO, 126(18), 2001, pp. 513-513

Authors: Raffenberg, M Szymanski, T Lubasch, A Erbes, R Wagner, S Weist, K Mansmann, U Lode, H
Citation: M. Raffenberg et al., Infections caused by Stenotrophomonas maltophilia (SMA) in patients in intensive care units: a prospective case-control study, DEUT MED WO, 126(18), 2001, pp. 514-518

Authors: Erbes, R Raffenberg, M Lode, H
Citation: R. Erbes et al., Idiopathic pulmonary fibrosis - Part 1: Diagnosis, DEUT MED WO, 126(14), 2001, pp. 395-398

Authors: Lode, H Erbes, R Raffenberg, M
Citation: H. Lode et al., Idiopathic pulmonary fibrosis - Part 2: Treatment, DEUT MED WO, 126(14), 2001, pp. 399-401

Authors: Woske, HJ Roding, T Schulz, I Lode, H
Citation: Hj. Woske et al., Ventilator-associated pneumonia in a surgical intensive care unit: epidemiology, etiology and comparison of three bronchoscopic methods for microbiological specimen sampling, CRIT CARE, 5(3), 2001, pp. 167-173

Authors: Lode, H
Citation: H. Lode, Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections, INT J ANT A, 18(3), 2001, pp. 199-209

Authors: Borner, K Borner, E Lode, H
Citation: K. Borner et al., Determination of linezolid in human serum and urine by high-performance liquid chromatography, INT J ANT A, 18(3), 2001, pp. 253-258

Authors: Lubasch, A Erbes, R Mauch, H Lode, H
Citation: A. Lubasch et al., Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapy, EUR RESP J, 17(4), 2001, pp. 641-646

Authors: Lode, H
Citation: H. Lode, Evidence of different profiles of side effects and drug-drug interactions among the quinolones - The pharmacokinetic standpoint, CHEMOTHERA, 47, 2001, pp. 24-31

Authors: Lode, H
Citation: H. Lode, Theme issue pneumology, DEUT MED WO, 125(8), 2000, pp. 205-205

Authors: Lode, H
Citation: H. Lode, Amoxicillin combined with clavulanic acid - Reply, DEUT MED WO, 125(31-32), 2000, pp. 957-957

Authors: Drusano, GL Lode, H Edwards, JR
Citation: Gl. Drusano et al., Meropenem: clinical response in relation to in vitro susceptibility, CL MICRO IN, 6(4), 2000, pp. 185-194

Authors: Lode, H Eller, J Raffenberg, M Mauch, H
Citation: H. Lode et al., Role of long-acting cephalosporins in the treatment of lower respiratory tract infections, CL MICRO IN, 6, 2000, pp. 87-89

Authors: File, T Schlemmer, B Garau, J Lode, H Lynch, S Young, C
Citation: T. File et al., Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis, J CHEMOTHER, 12(4), 2000, pp. 314-325

Authors: Lode, H Raffenberg, M Geerdes-Fenge, H Mauch, H
Citation: H. Lode et al., Monotherapy of nosocomial pneumonia, SEM RESP CR, 21(1), 2000, pp. 9-17

Authors: Lode, H Raffenberg, M Erbes, R Geerdes-Fenge, H Mauch, H
Citation: H. Lode et al., Nosocomial pneumonia: epidemiology, pathogenesis, diagnosis, treatment andprevention, CURR OPIN I, 13(4), 2000, pp. 377-384

Authors: Beyer, G Hiemer-Bau, M Ziege, S Edlund, C Lode, H Nord, CE
Citation: G. Beyer et al., Impact of moxifloxacin versus clarithromycin on normal oropharyngeal microflora, EUR J CL M, 19(7), 2000, pp. 548-550

Authors: Gluck, T Opal, S Alattar-Mantis, J Weitzel, T Lode, H Scholmerich, J
Citation: T. Gluck et al., Differences between American and German medical students and physicians inknowledge of infectious diseases, EUR J CL M, 19(11), 2000, pp. 868-870

Authors: Gluck, T Geerdes-Fenge, HF Straub, RH Raffenberg, M Lang, B Lode, H Scholmerich, J
Citation: T. Gluck et al., Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy, INFECTION, 28(4), 2000, pp. 227-230

Authors: Geerdes-Fenge, HF Wiedersich, A Wagner, S Lehr, KH Koeppe, P Lode, H
Citation: Hf. Geerdes-fenge et al., Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial species, ANTIM AG CH, 44(12), 2000, pp. 3478-3480

Authors: Lubasch, A Keller, I Borner, K Koeppe, P Lode, H
Citation: A. Lubasch et al., Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers, ANTIM AG CH, 44(10), 2000, pp. 2600-2603

Authors: Edlund, C Beyer, G Hiemer-Bau, M Ziege, S Lode, H Nord, CE
Citation: C. Edlund et al., Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora, SC J IN DIS, 32(1), 2000, pp. 81-85

Authors: Lode, H Lubasch, A Raffenberg, M Mauch, H
Citation: H. Lode et al., Clinical results in the treatment of respiratory infections with moxifloxacin, DRUGS TODAY, 36(4), 2000, pp. 245-253

Authors: Lubasch, A Lode, H
Citation: A. Lubasch et H. Lode, Utility of antibiotic therapy in infectious enteritis, INTERNIST, 41(5), 2000, pp. 494-497
Risultati: 1-25 | 26-44